vs
莫德纳（MRNA）与RANGE RESOURCES CORP（RRC）财务数据对比。点击上方公司名可切换其他公司
莫德纳的季度营收约是RANGE RESOURCES CORP的1.3倍（$1.0B vs $786.9M），RANGE RESOURCES CORP净利率更高（22.8% vs -19.7%，领先42.4%），RANGE RESOURCES CORP同比增速更快（18.0% vs -45.4%），过去两年RANGE RESOURCES CORP的营收复合增速更高（14.6% vs -45.0%）
莫德纳是一家总部位于美国马萨诸塞州剑桥市的生物制药企业，深耕RNA治疗领域，核心业务聚焦mRNA疫苗研发。其疫苗通过信使RNA（mRNA）分子拷贝传递蛋白合成指令以触发人体免疫反应，公司名称由“修饰”“RNA”与“现代”三个词组合而来。
Range Resources Corporation是一家总部位于美国得克萨斯州沃斯堡的天然气勘探开采企业，核心运营区域为马塞勒斯页岩地层，是该地区拥有土地面积最大的运营商，专注于天然气资源的勘探、开发与生产业务，在北美油气开发领域具备深厚的行业积累。
MRNA vs RRC — 直观对比
营收规模更大
MRNA
是对方的1.3倍
$786.9M
营收增速更快
RRC
高出63.4%
-45.4%
净利率更高
RRC
高出42.4%
-19.7%
两年增速更快
RRC
近两年复合增速
-45.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $786.9M |
| 净利润 | $-200.0M | $179.1M |
| 毛利率 | 79.6% | 94.5% |
| 营业利润率 | -25.6% | — |
| 净利率 | -19.7% | 22.8% |
| 营收同比 | -45.4% | 18.0% |
| 净利润同比 | -1638.5% | 88.8% |
| 每股收益（稀释后） | $-0.51 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MRNARRC
| Q4 25 | — | $786.9M | ||
| Q3 25 | $1.0B | $655.3M | ||
| Q2 25 | — | $699.6M | ||
| Q1 25 | — | $846.3M | ||
| Q4 24 | $966.0M | $667.0M | ||
| Q3 24 | $1.9B | $567.9M | ||
| Q2 24 | — | $513.2M | ||
| Q1 24 | — | $598.8M |
净利润MRNARRC
| Q4 25 | — | $179.1M | ||
| Q3 25 | $-200.0M | $144.3M | ||
| Q2 25 | — | $237.6M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | $-1.1B | $94.8M | ||
| Q3 24 | $13.0M | $50.7M | ||
| Q2 24 | — | $28.7M | ||
| Q1 24 | — | $92.1M |
毛利率MRNARRC
| Q4 25 | — | 94.5% | ||
| Q3 25 | 79.6% | 92.5% | ||
| Q2 25 | — | 95.0% | ||
| Q1 25 | — | 93.1% | ||
| Q4 24 | 23.5% | 93.7% | ||
| Q3 24 | 72.4% | 94.3% | ||
| Q2 24 | — | 93.4% | ||
| Q1 24 | — | 94.7% |
营业利润率MRNARRC
| Q4 25 | — | — | ||
| Q3 25 | -25.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -129.0% | — | ||
| Q3 24 | -3.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
净利率MRNARRC
| Q4 25 | — | 22.8% | ||
| Q3 25 | -19.7% | 22.0% | ||
| Q2 25 | — | 34.0% | ||
| Q1 25 | — | 11.5% | ||
| Q4 24 | -115.9% | 14.2% | ||
| Q3 24 | 0.7% | 8.9% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 15.4% |
每股收益（稀释后）MRNARRC
| Q4 25 | — | $0.75 | ||
| Q3 25 | $-0.51 | $0.60 | ||
| Q2 25 | — | $0.99 | ||
| Q1 25 | — | $0.40 | ||
| Q4 24 | $-2.91 | $0.38 | ||
| Q3 24 | $0.03 | $0.21 | ||
| Q2 24 | — | $0.12 | ||
| Q1 24 | — | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $204.0K |
| 总债务越低越好 | — | $1.2B |
| 股东权益账面价值 | $9.3B | $4.3B |
| 总资产 | $12.1B | $7.4B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资MRNARRC
| Q4 25 | — | $204.0K | ||
| Q3 25 | $1.1B | $175.0K | ||
| Q2 25 | — | $134.0K | ||
| Q1 25 | — | $344.6M | ||
| Q4 24 | $1.9B | $304.5M | ||
| Q3 24 | $1.6B | $277.4M | ||
| Q2 24 | — | $251.1M | ||
| Q1 24 | — | $343.1M |
总债务MRNARRC
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B | ||
| Q1 24 | — | $1.8B |
股东权益MRNARRC
| Q4 25 | — | $4.3B | ||
| Q3 25 | $9.3B | $4.2B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | — | $3.9B | ||
| Q4 24 | $10.9B | $3.9B | ||
| Q3 24 | $11.9B | $3.9B | ||
| Q2 24 | — | $3.9B | ||
| Q1 24 | — | $3.8B |
总资产MRNARRC
| Q4 25 | — | $7.4B | ||
| Q3 25 | $12.1B | $7.2B | ||
| Q2 25 | — | $7.1B | ||
| Q1 25 | — | $7.4B | ||
| Q4 24 | $14.1B | $7.3B | ||
| Q3 24 | $15.8B | $7.2B | ||
| Q2 24 | — | $7.3B | ||
| Q1 24 | — | $7.4B |
负债/权益比MRNARRC
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.44× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-847.0M | $257.5M |
| 自由现金流经营现金流 - 资本支出 | $-880.0M | — |
| 自由现金流率自由现金流/营收 | -86.6% | — |
| 资本支出强度资本支出/营收 | 3.2% | — |
| 现金转化率经营现金流/净利润 | — | 1.44× |
| 过去12个月自由现金流最近4个季度 | $-1.9B | — |
8季度趋势，按日历期对齐
经营现金流MRNARRC
| Q4 25 | — | $257.5M | ||
| Q3 25 | $-847.0M | $247.5M | ||
| Q2 25 | — | $336.2M | ||
| Q1 25 | — | $330.1M | ||
| Q4 24 | $825.0M | $217.9M | ||
| Q3 24 | $-1.6B | $245.9M | ||
| Q2 24 | — | $148.8M | ||
| Q1 24 | — | $331.9M |
自由现金流MRNARRC
| Q4 25 | — | — | ||
| Q3 25 | $-880.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $303.0M | — | ||
| Q3 24 | $-1.7B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率MRNARRC
| Q4 25 | — | — | ||
| Q3 25 | -86.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | -92.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度MRNARRC
| Q4 25 | — | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率MRNARRC
| Q4 25 | — | 1.44× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 3.40× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | -120.46× | 4.85× | ||
| Q2 24 | — | 5.18× | ||
| Q1 24 | — | 3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MRNA
| COVID19 | $971.0M | 96% |
| Other Revenue | $20.0M | 2% |
| Grant | $14.0M | 1% |
| Collaboration Arrangement Including Arrangements With Affiliate | $7.0M | 1% |
| License And Royalty | $2.0M | 0% |
RRC
| Natural Gas Natural Gas Liquids And Oil Sales | $745.5M | 95% |
| Brokered Natural Gas And Marketing | $41.3M | 5% |
